Bio-fabrication of silver nanoparticles by Pseudomonas aeruginosa: optimisation and antibacterial activity against selected waterborne human pathogens

Harnessing Nanoparticles to Overcome Antimicrobial Resistance: Promises and Challenges

The rise of antimicrobial resistance (AMR) has become a serious global health issue that kills millions of people each year globally. AMR developed in bacteria is difficult to treat and poses a challenge to clinicians. Bacteria develop resistance through a variety of processes, including biofilm growth, targeted area alterations, and therapeutic drug alteration, prolonging the period they remain within cells, where antibiotics are useless at therapeutic levels. This rise in resistance is linked to increased illness and death, highlighting the urgent need for effective solutions to combat this growing challenge. Nanoparticles (NPs) offer unique solutions for fighting AMR bacteria. Being smaller in size with a high surface area, enhancing interaction with bacteria makes the NPs strong antibacterial agents against various infections. In this review, we have discussed the epidemiology and mechanism of AMR development. Furthermore, the role of nanoparticles as antibacterial agents, and their role in drug delivery has been addressed. Additionally, the potential, challenges, toxicity, and future prospects of nanoparticles as antibacterial agents against AMR pathogens have been discussed. The research work discussed in this review links with Sustainable Development Goal 3 (SDG-3), which aims to ensure disease-free lives and promote well-being for all ages.

Nanomaterials for intelligent CRISPR-Cas tools: improving environment sustainability

Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) is a desirable gene modification tool covering a wide area in various sectors of medicine, agriculture, and microbial biotechnology. The role of this incredible genetic engineering technology has been extensively investigated; however, it remains formidable with cargo choices, nonspecific delivery, and insertional mutagenesis. Various nanomaterials including lipid, polymeric, and inorganic are being used to deliver the CRISPR-Cas system. Progress in nanomaterials could potentially address these challenges by accelerating precision targeting, cost-effectiveness, and one-step delivery. In this review, we highlighted the advances in nanotechnology and nanomaterials as smart delivery systems for CRISPR-Cas so as to ameliorate applications for environmental remediation including biomedical research and healthcare, strategies for mitigating antimicrobial resistance, and to be used as nanofertilizers for enhancing crop growth, and reducing the environmental impact of traditional fertilizers. The timely co-evolution of nanotechnology and CRISPR technologies has contributed to smart novel nanostructure hybrids for improving the onerous tasks of environmental remediation and biological sustainability.

Evaluation of Sclerotinia sclerotiorum MTCC 8785 as a biological agent for the synthesis of silver nanoparticles and assessment of their antifungal potential against Trichoderma harzianum MTCC 801

INTRODUCTION

Owing to loads of industrial development and advancements, there is an unmet need for green-ecosystem support as well as safe technologies. For cost-cutting and eco-friendly applications, biosynthetic pathways for nanoparticle synthesis from microbes like bacteria, and fungi have attracted the global attention of researchers.

METHODS

In the present research work, silver nanoparticles (AgNPs) from fungus (mycogenic) were extracellularly synthesized with cell-free filtrates of fungal phytopathogen Sclerotinia sclerotiorum MTCC 8785 harvested from broth culture in Potato dextrose broth (CFF-PDB) and Amylase production media (CFF-AMP). The synthesis was carried out at pH 7, 28 °C under dark conditions. The synthesized AgNPs were characterized using UV spectrophotometer and transmission electron microscopy (TEM). Furthermore, the antifungal efficacy of AgNPs was evaluated against the Trichoderma harzianum MTCC 801 strain by radial inhibition assay.

RESULTS

Primarily, the process of biosynthesis was inferred by the characteristic change of color and spectral peak at 420 nm recorded with UV spectrophotometer further approved the nano silver production in CFF-AMP which approves the role of amylases in reduction mediated capping process. TEM analysis revealed that the AgNPs synthesized using S. sclerotiorum MTCC 8785 grown in PDB were spherical with variable size ranges from 10 to 50 nm in diameter whereas, the AgNPs synthesized using S. sclerotiorum MTCC 8785 grown in APM were in the size ranges from 40 to 50 nm.

CONCLUSIONS

This is the first investigatory concern where nano-silver from fungal phytopathogen S. sclerotiorum MTCC 8785 has been prospected as new age antifungal alternatives against evolving threats from T. harzianum strain.